Clin Osteol 2016; 21(3): 92-95

Primary hyperparathyroidism with severe osteoporosis -relapse following five-year complete remissionShort communications

M. Krčma

Primary hyperparathyroidism, a complex disorder of calcium-phosphate metabolism affecting many organs and tissues, is one of less common causes of secondary osteoporosis. Metabolic changes are long-term and the disease is underdiagnosed. The present case re­ port shows some aspects and pitfalls of the diagnosis, treatment and follow-up.

Keywords: hyperparathyroidism, parathyroid glands, hypercalcemia., secondary osteoporosis Osteologický bulletin 2016, 21(3)992-95

Published: December 11, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krčma M. Primary hyperparathyroidism with severe osteoporosis -relapse following five-year complete remission. Osteologický bulletin. 2016;21(3):92-95.
Download citation

References

  1. Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiolo­ gy of the disease. J Bone Miner Res 2006;21(1): 171-177. Go to original source...
  2. Jodkowska A, Tupikowski K, Szymczak J, Bohdanowicz-Pawlak A, Bolanowski M, BednarekTupikowska G. Interdisciplinary Aspects of Primary Hyperparathyroidism: Symptomatology in a Series of 100 Cases. Adv Clin Exp Med 2016; 25(2):285-293. Go to original source...
  3. Broulík P, Adámek S, Libánský P, Kubinyi J. Changes in the Pttern of Primary Hyperparathyroidism in Czech Republic. Prague Med Rep 2015;116(2):112-121. Go to original source...
  4. Adámek S, Libánský P, Lischke R, Foltán R, Kubinyi J, Broulík P. Chirurgická léčba primární hyperparatyreózy v kontextu ortopedické diagnostiky a léčby: naše zkušenosti u 441 pacientů. Acta Chir Orthop Traumatol Cech 2011;78(4): 355-360. Go to original source...
  5. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperpara­ thyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 2014;99(10):3561-3569. Go to original source...
  6. The EVOLVE Trial Investigators, Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis. N Engl J Med 2012;367:2482-2494. Go to original source...
  7. Michaud L, Burgess A, Huchet V, Lefevre M, Tassart M, Ohnona J, Kerrou K, Balogova S, Talbot JN, Périé S. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctio­ ning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab 2014;99(12):4531^536. Go to original source...
  8. Lee IT, Sheu WH, Tu ST, Kuo SW, Pei D. Bisphosphonate pretreatment attenua­ te hungry bone syndrome postoperatively in subjects with primary hyperparathy­ roidism. J Bone Miner Metab 2006;24(3):255-258. Go to original source...
  9. Witteveen JE, van Thiel S, Romijn JA, Hamdy NA Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol 2013;168(3):R45-53. Go to original source...
  10. Hedbäck G, Odén A. Recurrence of hyperparathyroidism; a long-term follow-up after surgery for primary hyperparathyroidism. Eur J Endocrinol 2003;148(4): 413^21. Go to original source...




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.